Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2010
08/19/2010US20100212038 Transgenic fish with tissue-specific expression
08/19/2010US20100212037 Mia-2 protein
08/19/2010US20100212035 Compositions and Methods for Producing Transgenic Mammals Having Recombinant Immunoglobulin Loci
08/19/2010US20100212034 Method For Producing Unsaturated Omega-3-Fatty Acids In Transgenic Organisms
08/19/2010US20100212033 Novel ubiquitin lifases as therapeutic tragets
08/19/2010US20100212032 Compositions and Methods for the Efficient and Reproducible Generation of Clone Animals of All Developmental Stages and Methods of Use Thereof
08/19/2010US20100212029 Novel assays utilizing nicotinic acetylcholine receptor subunits
08/19/2010US20100210831 Immunocytokine Sequences and Uses Thereof
08/19/2010US20100210830 System for inducible expression in eukaryotic cells
08/19/2010US20100210827 Preparation Method Of Recombinant Protein By Use Of A Fusion Expression Partner
08/19/2010US20100210819 Biosensors to measure InsP3 concentration in living cells
08/19/2010US20100210818 Nucleic acids encoding the human alex1 protein
08/19/2010US20100210815 Insulin production methods and pro-insulin constructs
08/19/2010US20100210714 Her-2/neu DNA Vaccine Having Anti-Cancer Activity
08/19/2010US20100210712 Short RNA Antagonist Compounds for the Modulation of Target mRNA
08/19/2010US20100210710 THERAPEUTIC siRNA MOLECULES FOR REDUCING VEGFR1 EXPRESSION IN VITRO AND IN VIVO
08/19/2010US20100210551 Novel Bacillus Thuringiensis Crystal Polypeptides, Polynucleotides, and Compositions Thereof
08/19/2010US20100210550 Novel Bacillus Thuringiensis Crystal Polypeptides, Polynucleotides, and Compositions Thereof
08/19/2010US20100210549 Novel Bacillus Thuringiensis Crystal Polypetides, Polynucleotides, and Compositions Thereof
08/19/2010US20100210548 Novel Bacillus Thuringiensis Crystal Polypeptides, Polynucleotides, and Compositions Thereof
08/19/2010US20100210525 Combined preparation of a thiazide diuretic and a loop diuretic
08/19/2010US20100210514 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210513 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210508 Method for the Massive Culture of Cells Producing Recombinant Human Erythropoietin
08/19/2010US20100210479 Method of synthesis and testing of cominatorial libraries using microcapsules
08/19/2010US20100210018 Microbial host-vector complementation system
08/19/2010US20100210017 Compositions and methods for enhancing tolerance for the production of organic chemicals produced by microorganisms
08/19/2010US20100210015 Photochemical activation of surfaces for attaching biomaterial
08/19/2010US20100210012 Purified mammalian cytokines; related reagents and methods
08/19/2010US20100209999 Phage ømru polynucleotides and polypeptides and uses thereof
08/19/2010US20100209998 Cell-permeabilising peptides and polypeptides for microbial cells
08/19/2010US20100209997 Carbonic anhydrase polypeptides and uses thereof
08/19/2010US20100209996 Thermostable Alpha-Amylases
08/19/2010US20100209990 11 beta hydroxysteroid dehydrogenase type 1
08/19/2010US20100209987 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses
08/19/2010US20100209986 Biofuel production by recombinant microorganisms
08/19/2010US20100209985 Novel esterases and their use
08/19/2010US20100209981 Transaminase polypeptides
08/19/2010US20100209978 Gene-disrupted strain, recombinant plasmids, transformants and process for production of 3-carboxymuconolactone
08/19/2010US20100209974 Non-replicating paramyxoviridae virus vector
08/19/2010US20100209969 Geraniol synthase, methods of production and uses thereof
08/19/2010US20100209963 Photo-electric device and method for high throughput activation, guidance and poration of targeted cells with high spatial resolution
08/19/2010US20100209955 Methods For The Delivery Of Toxins Or Enzymatically Active Portions Thereof
08/19/2010US20100209936 Novel recombinant 15-kDa polypeptide and use of same in detecting human infection with Bartonella henselae
08/19/2010US20100209935 Nucleic Acid Ligand Diagnostic Biochip
08/19/2010US20100209933 Methods and Compositions for Detection and Enrichment of Target Small RNAs
08/19/2010US20100209931 Compositions for Identifying Novel Compositions for the Treatment of Disease and Methods of Using Same
08/19/2010US20100209923 Probe for diagnosis of marfan syndrome and a method for screening using the probe
08/19/2010US20100209922 Method of determining the nucleotide sequence of oligonucleotides and dna molecules
08/19/2010US20100209921 Digital Amplification
08/19/2010US20100209920 Gene Expression Profiling in Biopsied Tumor Tissues
08/19/2010US20100209919 Polynucleotide markers
08/19/2010US20100209907 Isolated mammalian monocyte cell genes; related reagents
08/19/2010US20100209905 Protein d - an igd-binding protein of haemophilus influenzae
08/19/2010US20100209491 Method for enhancing serum stability and lowering immune response of sirna down-regulating gene expression of hbv or hcv
08/19/2010US20100209487 Nicked or gapped nucleic acid molecules and uses thereof
08/19/2010US20100209453 Circovirus sequence associated with piglet weight loss disease (pwd)
08/19/2010US20100209451 Compositions and Methods Related to Adenovirus Based Delivery of Antigens
08/19/2010US20100209446 Ostertagia Vaccine
08/19/2010US20100209445 Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies
08/19/2010US20100209444 MAGE3 Polypeptides
08/19/2010US20100209440 Targeted Delivery of siRNA
08/19/2010US20100209435 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
08/19/2010US20100209432 Monoclonal antibodies against glypican-3
08/19/2010US20100209425 Blood-Brain Barrier Targeting Anti-bodies
08/19/2010US20100209422 Antibodies specific for the protofibril form of beta-amyloid protein
08/19/2010US20100209414 Methods and Compositions Related to Cyclic Peptide Synthesis
08/19/2010US20100209401 Use of SDF-1 to Improve Ischemic Myocardial Function
08/19/2010US20100209400 TAK1-Mediated Regulation of Osteogenesis
08/19/2010US20100209393 Use of Polynucleotides Encoding Small Acid-Soluble Spore Protein for Inhibiting Bacterial Cell Growth and/or Treating Bacterial Infections
08/19/2010US20100209392 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
08/19/2010US20100206730 Internal Calibration Standards for Electrophoretic Analyses
08/19/2010US20100206459 Polyamide resin and hinged molded product
08/19/2010US20100205857 Butanol production in a eukaryotic cell
08/19/2010US20100205754 Multi-Copper Oxidase CueO with Dyeability
08/19/2010CA2752489A1 Method for detecting presumed iga nephropathy and method for screening iga nephropathy patients
08/19/2010CA2752484A1 A method for promotion of flowering in rosaceae fruit trees using apple latent spherical virus vector
08/19/2010CA2752239A1 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
08/19/2010CA2752211A1 Fibronectin type iii domain based scaffold compositions, methods and uses
08/19/2010CA2752136A1 Anti-mst1r antibodies and uses thereof
08/19/2010CA2751977A1 C-cbl and antagonists thereof for the treatment and diagnosis of cancer
08/19/2010CA2751470A1 Template-independent ligation of single-stranded dna
08/19/2010CA2750991A1 Control of plant stress tolerance, water use efficiency and gene expression using novel aba receptor proteins and synthetic agonists
08/18/2010EP2218792A1 Method of preparing fecal sample, solution for preparing fecal sample and feces collection kit
08/18/2010EP2218791A1 Method and kit for preparation of sample for use in nucleic acid amplification
08/18/2010EP2218786A1 Mammalian artificial chromosome vector comprising human cytochrome p450 gene (cluster), and non-human mammalian animal retaining the same
08/18/2010EP2218785A2 Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
08/18/2010EP2218784A1 Vector(s) containing an inducible gene encoding a CDK4/CD6 inhibitor useful for treating neurodegenerative disorders
08/18/2010EP2218783A1 Novel method for the manufacturing of neurotoxins
08/18/2010EP2218782A2 Anti-OX40L Antibodies
08/18/2010EP2218781A1 RNAi based selection system
08/18/2010EP2218780A1 Nucleic acid amplification method, and reagent and reagent kit for use in the method
08/18/2010EP2218779A1 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
08/18/2010EP2218775A1 Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
08/18/2010EP2218773A1 Compositions and methods for degrading lignocellulosic biomass
08/18/2010EP2218771A1 Needle
08/18/2010EP2218770A1 Chip drive
08/18/2010EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction
08/18/2010EP2218733A1 Compounds and methods for treatment and diagnosis of chlamydial infection
08/18/2010EP2218732A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
1 ... 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 ... 4023